A fluorescence study of type I and type II receptors of bone morphogenetic proteins with bis-ANS (4, 4′-dianilino-1, 1′-bisnaphthyl-5, 5′ disulfonic acid)

Biochimica et Biophysica Acta - Proteins and Proteomics

Volumn 1774, Issue 4, 2007, Pages 493-501

  Yin, Huiran ^a   Zhou, Qing ^a   Panda, Markandeswar ^a   Yeh, Lee Chuan C ^a   Zavala, Michelle C ^a   Lee, John C ^a  

^a Mays Cancer Center at UT Health San Antonio   (United States)

Author keywords

bis ANS; BMP receptors; Fluorescence; Hydrophobic surface; Protein structure

Indexed keywords

4,4' DIANILINO 1,1' BISNAPHTHYL 5,5' DISULFONIC ACID; ANILINE DERIVATIVE; BONE MORPHOGENETIC PROTEIN RECEPTOR 1; BONE MORPHOGENETIC PROTEIN RECEPTOR 2; DYE; NAPHTHALENE DERIVATIVE; SULFONIC ACID DERIVATIVE; TRYPTOPHAN; TYROSINE; UNCLASSIFIED DRUG;

ARTICLE; BINDING SITE; ENERGY TRANSFER; FLUORESCENCE; HUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN STRUCTURE; RECEPTOR BINDING; STRUCTURE ANALYSIS;

ANILINO NAPHTHALENESULFONATES; BINDING SITES; BONE MORPHOGENETIC PROTEIN RECEPTORS, TYPE I; BONE MORPHOGENETIC PROTEIN RECEPTORS, TYPE II; FLUORESCENCE RESONANCE ENERGY TRANSFER; FLUORESCENT DYES; HUMANS; HYDROPHOBICITY; SPECTROMETRY, FLUORESCENCE; TYROSINE;

EID: 33947660027     PISSN: 15709639     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbapap.2007.02.003     Document Type: Article

References (42)

1. Ozkaynak E., Rueger D.C., Drier E.A., Corbett C., Ridge R.J., Sampath T.K., and Oppermann H. OP-1 cDNA encodes an osteogenic protein in the TGF-beta family. EMBO J. 9 (1990) 2085-2093
2. Sampath T.K., Maliakal J.C., Hauschka P.V., Jones W.K., Sasak H., Tucker R.F., White K.H., Coughlin J.E., Tucker M.M., Pang R.H., Corbett C., Ozkaynak E., Oppermann H., and Rueger D.C. Recombinant human osteogenic protein-1 (hOP-1) induces new bone formation in vivo with a specific activity comparable with natural bovine osteogenic protein and stimulates osteoblast proliferation and differentiation in vitro. J. Biol. Chem. 267 (1992) 20352-20362
3. Kingsley D.M. The TGF-beta superfamily: new members, new receptors, and new genetic tests of function in different organisms. Genes Dev. 8 (1994) 133-146
4. Hogan B.L. Bone morphogenetic proteins: multifunctional regulators of vertebrate development. Genes Dev. 10 (1996) 1580-1594
5. Reddi A.H. Bone morphogenetic proteins and skeletal development: the kidney-bone connection. [In Process Citation]. Pediatr. Nephrol. 14 (2000) 598-601
6. Wozney J.M., and Rosen V. Bone morphogenetic protein and bone morphogenetic protein gene family in bone formation and repair. Clin. Orthop. 346 (1998) 26-37
7. ten Dijke P., Miyazono K., and Heldin C.H. Signaling inputs converge on nuclear effectors in TGF-beta signaling. Trends Biochem. Sci. 25 (2000) 64-70
8. Massague J. TGF-beta signal transduction. Annu. Rev. Biochem. 67 (1998) 753-791
9. Rosenzweig B.L., Imamura T., Okadome T., Cox G.N., Yamashita H., ten Dijke P., Heldin C.H., and Miyazono K. Cloning and characterization of a human type II receptor for bone morphogenetic proteins. Proc. Natl. Acad. Sci. U. S. A. 92 (1995) 7632-7636
10. ten Dijke P., Yamashita H., Sampath T.K., Reddi A.H., Estevez M., Riddle D.L., Ichijo H., Heldin C.H., and Miyazono K. Identification of type I receptors for osteogenic protein-1 and bone morphogenetic protein-4. J. Biol. Chem. 269 (1994) 16985-16988
11. Yamashita H., ten Dijke P., Huylebroeck D., Sampath T.K., Andries M., Smith J.C., Heldin C.H., and Miyazono K. Osteogenic protein-1 binds to activin type II receptors and induces certain activin-like effects. J. Cell Biol. 130 (1995) 217-226
12. Macias-Silva M., Hoodless P.A., Tang S.J., Buchwald M., and Wrana J.L. Specific activation of Smad1 signaling pathways by the BMP7 type I receptor, ALK2. J. Biol. Chem. 273 (1998) 25628-25636
13. Greenwald J., Le V., Corrigan A., Fischer W., Komives E., Vale W., and Choe S. Characterization of the extracellular ligand-binding domain of the type II activin receptor. Biochemistry 37 (1998) 16711-16718
14. Gray P.C., Greenwald J., Blount A.L., Kunitake K.S., Donaldson C.J., Choe S., and Vale W. Identification of a binding site on the type II activin receptor for activin and inhibin. J. Biol. Chem. 275 (2000) 3206-3212
15. Greenwald J., Fischer W.H., Vale W.W., and Choe S. Three-finger toxin fold for the extracellular ligand-binding domain of the type II activin receptor serine kinase. Nat. Struct. Biol. 6 (1999) 18-22
16. Mace P.D., Cutfield J.F., and Cutfield S.M. High resolution structures of the bone morphogenetic protein type II receptor in two crystal forms: implications for ligand binding. Biochem. Biophys. Res. Commun. 351 (2006) 831-838
17. Yin H., Ilangovan U., Hinck A.P., and Lee J.C. Sequential resonance assignment of the human BMP type II receptor extracellular domain. J. Biomol. NMR 32 (2005) 336
18. Hinck A.P., Walker III K.P., Martin N.R., Deep S., Hinck C.S., and Freedberg D.I. Sequential resonance assignments of the extracellular ligand binding domain of the human TGF-beta type II receptor. J. Biomol. NMR 18 (2000) 369-370
19. Marlow M.S., Brown C.B., Barnett J.V., and Krezel A.M. Solution structure of the chick TGFbeta type II receptor ligand-binding domain. J. Mol. Biol. 326 (2003) 989-997
20. Boesen C.C., Radaev S., Motyka S.A., Patamawenu A., and Sun P.D. The 1.1 A crystal structure of human TGF-beta type II receptor ligand binding domain. Structure 10 (2002) 913-919
21. Thompson T.B., Woodruff T.K., and Jardetzky T.S. Structures of an ActRIIB:activin A complex reveal a novel binding mode for TGF-beta ligand:receptor interactions. EMBO J. 22 (2003) 1555-1566
22. Greenwald J., Vega M.E., Allendorph G.P., Fischer W.H., Vale W., and Choe S. A flexible activin explains the membrane-dependent cooperative assembly of TGF-beta family receptors. Mol. Cell 15 (2004) 485-489
23. Greenwald J., Groppe J., Gray P., Wiater E., Kwiatkowski W., Vale W., and Choe S. The BMP7/ActRII extracellular domain complex provides new insights into the cooperative nature of receptor assembly. Mol. Cell 11 (2003) 605-617
24. Kirsch T., Sebald W., and Dreyer M.K. Crystal structure of the BMP-2-BRIA ectodomain complex [see comments]. Nat. Struct. Biol. 7 (2000) 492-496
25. Nickel J., Kotzsch A., Sebald W., and Mueller T.D. A single residue of GDF-5 defines binding specificity to BMP receptor IB. J. Mol. Biol. 349 (2005) 933-947
26. Allendorph G.P., Vale W.W., and Choe S. Structure of the ternary signaling complex of a TGF-beta superfamily member. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 7643-7648
27. Hart P.J., Deep S., Taylor A.B., Shu Z., Hinck C.S., and Hinck A.P. Crystal structure of the human TbetaR2 ectodomain-TGF-beta3 complex. Nat. Struct. Biol. 9 (2002) 203-208
28. Wuytens G., Verschueren K., de Winter J.P., Gajendran N., Beek L., Devos K., Bosman F., de Waele P., Andries M., van den Eijnden-van Raaij A.J., Smith J.C., and Huylebroeck D. Identification of two amino acids in activin A that are important for biological activity and binding to the activin type II receptors. J. Biol. Chem. 274 (1999) 9821-9827
29. Keller S., Nickel J., Zhang J.L., Sebald W., and Mueller T.D. Molecular recognition of BMP-2 and BMP receptor IA. Nat. Struct. Mol. Biol. 11 (2004) 481-488
30. Hatta T., Konishi H., Katoh E., Natsume T., Ueno N., Kobayashi Y., and Yamazaki T. Identification of the ligand-binding site of the BMP type IA receptor for BMP-4. Biopolymers 55 (2000) 399-406
31. Natsume T., Tomita S., Iemura S., Kinto N., Yamaguchi A., and Ueno N. Interaction between soluble type I receptor for bone morphogenetic protein and bone morphogenetic protein-4. J. Biol. Chem. 272 (1997) 11535-11540
32. Kirsch T., Nickel J., and Sebald W. BMP-2 antagonists emerge from alterations in the low-affinity binding epitope for receptor BMPR-II. EMBO J. 19 (2000) 3314-3324
33. Young L., Jernigan R.L., and Covell D.G. A role for surface hydrophobicity in protein-protein recognition. Protein Sci. 3 (1994) 717-729
34. Clackson T., and Wells J.A. A hot spot of binding energy in a hormone-receptor interface. Science 267 (1995) 383-386
35. Schagger H., and von Jagow G. Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. Anal. Biochem. 166 (1987) 368-379
36. Sudhakar K., and Fay P.J. Exposed hydrophobic sites in factor VIII and isolated subunits. J. Biol. Chem. 271 (1996) 23015-23021
37. Lakowicz J.R. Principles of Fluorescence Spectroscopy (1999), Book, Kluwer Academic/Plenum Publishers, New York 54
38. Seale J.W., Martinez J.L., and Horowitz P.M. Photoincorporation of 4,4′-bis(1-anilino-8-naphthalenesulfonic acid) into the apical domain of GroEL: specific information from a nonspecific probe. Biochemistry 34 (1995) 7443-7449
39. Turner D.C., and Brand L. Quantitative estimation of protein binding site polarity. Fluorescence of N-arylaminonaphthalenesulfonates. Biochemistry 7 (1968) 3381-3390
40. Stryer L. The interaction of a naphthalene dye with apomyoglobin and apohemoglobin. A fluorescent probe of non-polar binding sites. J. Mol. Biol. 13 (1965) 482-495
41. Calhoun D.B., Vanderkooi J.M., Holtom G.R., and Englander S.W. Protein fluorescence quenching by small molecules: protein penetration versus solvent exposure. Proteins 1 (1986) 109-115
42. Eftink M.R., and Ghiron C.A. Fluorescence quenching studies with proteins. Anal. Biochem. 114 (1981) 199-227